Membranous nephropathy is the most frequent cause of glomerulonephriti
s in adults with nephrotic syndrome, Approximately one quarter of the
patients develop end-stage renal disease, Another quarter enters compl
ete remission during follow-up, Treating all patients with membranous
nephropathy with immunosuppressive drugs would unnecessarily expose at
least one quarter of the patients to these toxic drugs, Identifying p
atients at highest risk would allow tailor-made treatment, Many risk f
actors have been found, such as male sex, HLA type DR3+/B8+, white rac
e, advanced age, and tubulointerstitial changes or focal sclerosis fou
nd with renal biopsy, In addition, nephrotic syndrome, elevation of im
munoglobulin G excretion or beta(2)-microglobulin excretion, low serum
albumin, high serum cholesterol, an elevation of urinary excretion of
complement activation products, impaired renal function at diagnosis,
and, finally, hypertension are associated with a higher risk of renal
function deterioration during follow-up, We have critically reviewed
the literature and summarized the clinical significance of the above-m
entioned risk factors in predicting subsequent renal function deterior
ation in patients with membranous nephropathy. (C) 1998 by the Nationa
l Kidney Foundation, Inc.